Cargando…

Activation-induced Markers Detect Vaccine-Specific CD4(+) T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials

Immunogenicity of T cell-inducing vaccines, such as viral vectors or DNA vaccines and Bacillus Calmette-Guérin (BCG), are frequently assessed by cytokine-based approaches. While these are sensitive methods that have shown correlates of protection in various vaccine studies, they only identify a smal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bowyer, Georgina, Rampling, Tommy, Powlson, Jonathan, Morter, Richard, Wright, Daniel, Hill, Adrian V.S., Ewer, Katie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161310/ https://www.ncbi.nlm.nih.gov/pubmed/30065162 http://dx.doi.org/10.3390/vaccines6030050

Ejemplares similares

Characterization of Antigenic MHC-Class-I-Restricted T Cell Epitopes in the Glycoprotein of Ebolavirus
por: Powlson, Jonathan, et al.
Publicado: (2019)

CXCR3(+) T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria
por: Bowyer, Georgina, et al.
Publicado: (2018)

Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid
por: Lambe, Teresa, et al.
Publicado: (2016)

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
por: Venkatraman, Navin, et al.
Publicado: (2019)

A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
por: Lambe, Teresa, et al.
Publicado: (2017)

Reduced Ebola vaccine responses in CMV(+) young adults is associated with expansion of CD57(+)KLRG1(+) T cells
por: Bowyer, Georgina, et al.
Publicado: (2020)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
por: Folegatti, Pedro M., et al.
Publicado: (2019)

Development of an In Vitro Assay and Demonstration of Plasmodium berghei Liver-Stage Inhibition by TRAP-Specific CD8(+) T Cells
por: Longley, Rhea J., et al.
Publicado: (2015)

Development of an in vitro Plasmodium parasite killing assay for the evaluation of cell-mediated immune responses following vaccination with pre-erythrocytic malaria vaccine candidates
por: Bliss, Carly M, et al.
Publicado: (2014)

Cryopreservation-related loss of antigen-specific IFNγ producing CD4(+) T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy
por: Ford, Tom, et al.
Publicado: (2017)

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
por: Sharpe, Hannah R., et al.
Publicado: (2022)

Towards a multi-antigen multi-stage malaria vaccine
por: Hill, Adrian VS, et al.
Publicado: (2014)

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
por: Morter, Richard, et al.
Publicado: (2022)

Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
por: Rampling, Tommy, et al.
Publicado: (2018)

Humoral immunogenicity of ChAd63_MVA ME-TRAP vaccination in African infants and children
por: Bowyer, Georgina, et al.
Publicado: (2014)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
por: Ewer, Katie J., et al.
Publicado: (2015)

An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens
por: Rodríguez-Galán, Ana, et al.
Publicado: (2017)

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
por: Tiono, Alfred B., et al.
Publicado: (2018)

Deep Immune Phenotyping and Single-Cell Transcriptomics Allow Identification of Circulating TRM-Like Cells Which Correlate With Liver-Stage Immunity and Vaccine-Induced Protection From Malaria
por: Noé, Andrés, et al.
Publicado: (2022)

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01(B) With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
por: Rampling, Tommy, et al.
Publicado: (2016)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017)

Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man
por: Flaxman, Amy, et al.
Publicado: (2018)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
por: Bliss, Carly M., et al.
Publicado: (2018)

Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1
por: Berthoud, Tamara K., et al.
Publicado: (2011)

The 2022 monkeypox outbreak: the need for clinical curiosity
por: Gordon, N Claire, et al.
Publicado: (2023)

Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle
por: Dulal, Pawan, et al.
Publicado: (2016)

Marker-based assays for studying gut transit in gnotobiotic and conventional mouse models
por: Koester, Sean T., et al.
Publicado: (2021)

International Biological Reference Preparations for Epidemic Infectious Diseases
por: Rampling, Tommy, et al.
Publicado: (2019)

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals
por: Hodgson, Susanne H., et al.
Publicado: (2015)

Profiling the host response to malaria vaccination and malaria challenge
por: Dunachie, Susanna, et al.
Publicado: (2015)

Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses
por: Rollier, Christine S., et al.
Publicado: (2016)

Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
por: Mensah, Victorine A., et al.
Publicado: (2017)

Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells
por: Reiss, Samantha, et al.
Publicado: (2017)

Immunogenicity of ChAd63 + MVA ME-TRAP in Senegalese adults
por: Mensah, Victorine, et al.
Publicado: (2014)

Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants
por: Bliss, Carly M., et al.
Publicado: (2017)

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates
por: Longley, Rhea J., et al.
Publicado: (2015)

Rapid Effector Function in CD8(+) Memory T Cells
por: Lalvani, Ajit, et al.
Publicado: (1997)

Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice
por: Longley, Rhea J., et al.
Publicado: (2015)

The RNA disruption assay is superior to conventional drug sensitivity assays in detecting cytotoxic drugs
por: Mapletoft, Jonathan P. J., et al.
Publicado: (2020)

Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine
por: Longley, Rhea J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mqa7c4ck6pkmfnfq81hp0n6n7c